Teva to invest $100 mln in Hungarian drug factory

BUDAPEST, March 17 (Reuters) - Israel's Teva Pharmaceutical Industries (TEVA.O: Quote, Profile, Research) will invest $100 million to double capacity at one of its drug making units in Hungary by 2010, the firm said in a statement on Monday.

The unit is based in Debrecen, Eastern Hungary.

Teva, which has spent a combined $630 million in Hungary on investments and research and development since 1995, has three manufacturing sites in Hungary.

Hungary is also centre of the firm's European operations.

Teva's consolidated sales in Hungary last year were 175 billion forints ($1.06 billion). (Reporting by Gergely Szakacs)